Importantly, manganese supplementation was recently shown to correct biochemical abnormalities (glycosylation and blood manganese levels) and resulted in tangible clinical improvement in patients with SLC39A8 deficiency with little evidence of toxicity36. This evidence concerns the gene SLC39A8 and hyperinsulinemic hypoglycemia, familial, 4.